ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VER Vernalis

6.17
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vernalis LSE:VER London Ordinary Share GB00B3Y5L754 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.17 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vernalis Share Discussion Threads

Showing 3351 to 3375 of 3850 messages
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older
DateSubjectAuthorDiscuss
04/8/2017
13:49
Anyone know when we are likely to get the news...??
chrisdgb
04/8/2017
10:40
It wouldn't be a disaster, it would be disappointing in the same way as CCP-07 was disappointing. The damage to strategy may already been done unless they continue with the training for sales staff on both products on the expectation of approval for CCP-07 H1 next year.

Based on the wall of silence from Garland, we can only assume Moxatag or CCP-07 will not be in the market any time soon, today we might be adding CCP-08 to that list.

I would not be surprised if CCP-08 is rejected on the same basis as CCP-07 unless Tris / Vernalis have sorted out whatever the issue was. Of course we don't know what the issue was because Garland has gone to ground. The biggest loser from a failure to win approval for CCP-08 could end up being Garland himself.

romeike
03/8/2017
16:00
If CP08 is knocked back tomorrow it will be a disaster for the change of strategy.Everything crossed for a clear run and two products in next seasons market.
fhmktg
03/8/2017
15:53
I'm sure I am as irritated by Vernalis lack of communication as anyone else but that "simpvestor" analysis seems a bit basic and very one sided.

TXR was expected initially to replace lost revenue from Frovatriptan. In this regard it is a success. We'd all like it to be getting more revenue but the product looks expensive in the context of a US market that is looking for cheaper drug prices and discounts should be expected. I don't think anyone is expecting TXR to carry the company. The analysis also completely ignores the research area which we know has already outperformed full year expectations.

The major points Garland needs to answer are:
WTF is happening with Moxatag - promises were made re: progress on this and time is up
WTF is happening with CCP-07??? - lack of detail on this and its impact on sales strategy / costs is a disgrace

romeike
02/8/2017
12:04
Hoping the FDA can give us a happy Friday.............!!
chrisdgb
01/8/2017
15:35
Here's some thoughtful insight on the recent Vernalis market update:



Will leave you to draw your own conclusions

megasonic
01/8/2017
15:16
Just checked pdufa date is 4th August.
fhmktg
01/8/2017
15:14
Some gentle mopping up this afternoon?Can't be good news coming surely.Though CP08 should be coming through soon.
fhmktg
25/7/2017
10:10
If this latest update is anything but very good news I think it will be time for Mr Garland to forgo his gold plated salary and bonus and leave.
romeike
18/7/2017
08:42
Plenty of room to bounce higher, just don't seem to have the natural buyers....
chrisdgb
18/7/2017
08:25
CCP-08 approval statement is due in August. I would hope for better news on both 07 and 08 by the September results or the whole franchise could be in trouble.
fhmktg
18/7/2017
08:24
makes a change
bountyhunter
18/7/2017
07:54
PILE in NOW
hvs
14/7/2017
10:46
Agreed, we could do with a dose of good news for a change......
chrisdgb
14/7/2017
08:14
The run rate at June 30th for Tuzistra was touted as an indicator for future potential in the interim report.So the pre results update for the year to end June is very important, plus updates on the later CP series, plus Moxatag 'news'I had expected this during the last week.Hope this delay does not suggest bad news coming!
fhmktg
12/7/2017
14:22
When there is blood on the streets and all that..........
chrisdgb
12/7/2017
13:49
...at least I have some oxb to balance out the horrendous situation here, certainly in the running for my most disappointing share, ...maybe one day things will change!
bountyhunter
12/7/2017
13:39
Couldn't be more despondent.
fhmktg
12/7/2017
13:18
Pretty low volumes but a few buys possibly hoping for an imminent update..?
chrisdgb
26/6/2017
07:39
Around 7th July for the year end trading update.Poor communication so far, of what is happening with the FDA and Moxatag.With another review of CP08 due soon, let's hope we get a clear idea of strategy for the coming years!Looking like a turkey at the moment.
fhmktg
23/6/2017
12:06
Next news anyone...???
chrisdgb
08/6/2017
07:22
absolutely
bountyhunter
07/6/2017
16:06
Lets hope not.

Management buyouts are a nightmare for investors. 10 cents on the dollar if you're lucky.

bantam175
07/6/2017
08:17
Nothing worth having until the Tris products have shown their metal....or not.A management buy out could be a possibility?
fhmktg
07/6/2017
07:46
Any chance of a takeover..??
chrisdgb
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older

Your Recent History

Delayed Upgrade Clock